Findings involving antibody effector functions could help improve design of next-generation COVID-19 antibody drugs
Category: GTAC News
U.S. rushes to fill void in viral sequencing as worrisome coronavirus variants spread (Links to an external site)
By Meredith Wadman Since May 2020, Jeffrey Milbrandt has had his systems fine-tuned to sequence 1000 coronavirus samples a week. The director of a major sequencing center at Washington University in St. Louis (WashU), Milbrandt knew months ago that the United States urgently needed to identify and track emerging variants of SARS-CoV-2, the pandemic coronavirus already […]
PercayAI and Saint Louis University Partner to Accelerate AI Adoption across Biomedical Sciences Research (Links to an external site)
Combating COVID-19 (Links to an external site)
Medical school labs pivot to fight a common enemy
Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay (Links to an external site)
Fluidigm said on Thursday that it has received the CE-IVD mark for its Advanta Dx SARS-CoV-2 RT-PCR assay, an extraction-free saliva-based test to detect nucleic acid from the SARS-CoV-2 virus.
Washington University Laboratory Develops COVID-19 Saliva Test for Screening on a Massive Scale (Links to an external site)
By Kathleen Berger, Executive Producer for Science & Technology
Washington University Spit Test Approved by FDA for Virus (Links to an external site)
A Washington University spit test for the coronavirus has been approved by the Food and Drug Administration.